CAS RN: 13957-31-8
4-THIOURIDINE
Product Availability
Choose a grade to view its available package options.
2 package records 1 with current stock 2 grade groups
Grade
98% (1)
99.50% (1)
In stock only
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20260226
5mg / 25mg / 100mg / 250mg / 1g / 5g
Confirm by inquiry
Shandong, Shanghai, Hebei Inquiry
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20250416
5mg
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥98%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 13957-31-8
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥98%
0
Out of Stock
Hong Kong
Inquiry
13957-31-8 / 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-sulfanylidenepyrimidin-2-one
Standard CAS: 13957-31-8
Multi CAS: No
Basic Information
copy
CAS
13957-31-8 copy
Multi CAS
No copy
Molecular Formula
C9H12N2O5S copy
Molecular Weight
260.270000 copy
Exact Mass
260.046693 copy
SMILES
C1=CN(C(=O)NC1=S)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O copy
InChI
InChI=1S/C9H12N2O5S/c12-3-4-6(13)7(14)8(16-4)11-2-1-5(17)10-9(11)15/h1-2,4,6-8,12-14H,3H2,(H,10,15,17)/t4-,6-,7-,8-/m1/s1 copy
InChIKey
ZLOIGESWDJYCTF-XVFCMESISA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
17 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.56 copy
Rotatable bonds
2 copy
H-bond acceptors
7 copy
H-bond donors
4 copy
Molar refractivity
58.9 copy
TPSA
107.71 copy
LogP / Solubility
WLOGP
-1.48 copy
MLOGP
-1.3 copy
XLogP3
-1.4 copy
Consensus LogP
-1.39 copy
Log S (ESOL)
-0.65 copy
Class (ESOL)
Very soluble copy
Log S (Ali)
-0.62 copy
Class (Ali)
Very soluble copy
Log S (SILICOS-IT)
-0.36 copy
Class (SILICOS-IT)
Very soluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-5.36 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
Yes copy
Synthetic Accessibility
3.5 copy